H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Go back to H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 6.65 +2.44 (57.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.21 | 52 Week High | $5.40 | |||
| Open | $7.66 | 52 Week Low | $1.88 | |||
| Day High | $8.15 | P/E | N/A | |||
| Day Low | $6.04 | EPS | $0.00 | |||
| Volume | 65,950,357 | |||||
